Healthcare provider profile · identity verified

Misal Khan, MD

General Practice · PANAMA CITY, FL · NPI 1265405286

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	493	60
Atorvastatin Calcium	Atorvastatin Calcium	434	112
Amlodipine Besylate	Amlodipine Besylate	332	90
Albuterol Sulfate Hfa	Albuterol Sulfate	299	80
Metoprolol Succinate	Metoprolol Succinate	299	80
Lisinopril	Lisinopril	248	71
Omeprazole	Omeprazole	235	64
Alprazolam	Alprazolam	224	31
Gabapentin	Gabapentin	195	61
Levothyroxine Sodium	Levothyroxine Sodium	193	50
Metformin Hcl	Metformin Hcl	188	49
Famotidine	Famotidine	181	46
Furosemide	Furosemide	170	48
Carvedilol	Carvedilol	154	44
Tramadol Hcl	Tramadol Hcl	148	31
Potassium Chloride	Potassium Chloride	142	41
Rosuvastatin Calcium	Rosuvastatin Calcium	135	43
Losartan Potassium	Losartan Potassium	133	42
Trazodone Hcl	Trazodone Hcl	132	39
Baclofen	Baclofen	121	39
Montelukast Sodium	Montelukast Sodium	116	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	114	32
Varenicline Tartrate	Varenicline Tartrate	103	22
Tamsulosin Hcl	Tamsulosin Hcl	97	29
Fluticasone Propionate	Fluticasone Propionate	95	27
Clopidogrel	Clopidogrel Bisulfate	91	29
Prednisone	Prednisone	90	61
Azithromycin	Azithromycin	83	52
Glipizide	Glipizide	78	19
Pravastatin Sodium	Pravastatin Sodium	77	21
Pantoprazole Sodium	Pantoprazole Sodium	76	20
Breo Ellipta	Fluticasone/Vilanterol	75	26
Hydrochlorothiazide	Hydrochlorothiazide	72	27
Meloxicam	Meloxicam	67	28
Eliquis	Apixaban	63	17
Citalopram Hbr	Citalopram Hydrobromide	62	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	19
Tradjenta	Linagliptin	59	11
Allopurinol	Allopurinol	55	16
Symbicort	Budesonide/Formoterol Fumarate	55	12
Atenolol	Atenolol	54	15
Farxiga	Dapagliflozin Propanediol	52	17
Glipizide Er	Glipizide	51	11
Diclofenac Sodium	Diclofenac Sodium	49	12
Ibuprofen	Ibuprofen	49	14
Vitamin D2	Ergocalciferol (Vitamin D2)	49	17
Fluconazole	Fluconazole	46	22
Levetiracetam	Levetiracetam	46	suppressed
Meclizine Hcl	Meclizine Hcl	43	11
Oxybutynin Chloride Er	Oxybutynin Chloride	43	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	suppressed
Nitroglycerin	Nitroglycerin	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	32
Triamcinolone Acetonide	Triamcinolone Acetonide	41	24
Ezetimibe	Ezetimibe	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	29
Alendronate Sodium	Alendronate Sodium	34	15
Pregabalin	Pregabalin	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Nystatin	Nystatin	31	15
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Olanzapine	Olanzapine	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	11
Hydralazine Hcl	Hydralazine Hcl	28	12
Penicillin V Potassium	Penicillin V Potassium	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Sertraline Hcl	Sertraline Hcl	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Levofloxacin	Levofloxacin	25	16
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Lactulose	Lactulose	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Clindamycin Hcl	Clindamycin Hcl	20	13
Comfort Ez Pen Needle	Pen Needle, Diabetic	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Klor-Con 10	Potassium Chloride	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	12
Mirtazapine	Mirtazapine	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Cephalexin	Cephalexin	16	14
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Amoxicillin	Amoxicillin	15	11
Divalproex Sodium	Divalproex Sodium	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Clomipramine Hcl	Clomipramine Hcl	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Risperidone	Risperidone	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error